<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8645">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00817804</url>
  </required_header>
  <id_info>
    <org_study_id>V60-1050766VP v 2.3</org_study_id>
    <nct_id>NCT00817804</nct_id>
  </id_info>
  <brief_title>Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators</brief_title>
  <official_title>Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators for Pediatric Patients With Respiratory Failure or Respiratory Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Respironics, California, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Respironics, California, Inc.</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare a new noninvasive ventilator to existing ventilators
      already used for patient care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study compares the Respironics California V60 Mask ventilator to conventional
      noninvasive ventilators in a cross-over study with the patient as his/her own control.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Breathing Comfort</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Saturation of Arterial Oxygen</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minute Ventilation</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>30 minutes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>V60 then Conventional</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study device first</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional then V60</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conventional device first</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Use of the V60 Mask Ventilator</intervention_name>
    <description>The V60 Mask Ventilator used to provide noninvasive ventilation. It is compared to the patient's conventional ventilator in a cross-over study. The ventilator settings can range from CPAP to Pressure Support ventilation with values of IPAP and EPAP to match the conventional ventilation on which the patient had been placed.</description>
    <arm_group_label>V60 then Conventional</arm_group_label>
    <arm_group_label>Conventional then V60</arm_group_label>
    <other_name>V60 is the Philips V60 Ventilator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 7 years and &lt; 18 years

          -  Weight &gt; 20 kg (44 lbs)

          -  Respiratory failure or respiratory insufficiency

          -  Ability to cooperate with the investigators

          -  Designated adult able to provide Informed Consent

        Exclusion Criteria:

          -  An endotracheal tube or tracheostomy in place

          -  Hemodynamically instability

          -  Prolonged apnea

          -  Inability to maintain the airway

          -  A recent history of cardiac and or respiratory arrest

          -  Acute hemorrhage

          -  Multiple organ system failure

          -  Undrained pneumothorax

          -  High risk for aspiration

          -  Metastatic or terminal cancer

          -  Do-not-resuscitate orders

          -  Inability to clear respiratory secretions

          -  Inability to fit a mask

          -  Facial surgery, trauma, or deformity

          -  Upper gastrointestinal or airway surgery

          -  Pregnancy

          -  Refractory delirium

          -  PaO2 &lt; 50 mmHg on present settings

          -  Designee unable or unwilling to provide Informed Consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Mink, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba, Winnipeg, Manitoba, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GF-221 Health Sciences Centre</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0Z3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <lastchanged_date>August 12, 2009</lastchanged_date>
  <firstreceived_date>January 3, 2009</firstreceived_date>
  <firstreceived_results_date>May 5, 2009</firstreceived_results_date>
  <responsible_party>
    <name_title>Dr. Steven Mink</name_title>
    <organization>Professor of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada</organization>
  </responsible_party>
  <keyword>noninvasive ventilation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Hospitalized adult patients enrolled between Jan 17 and Mar 3, 2009.</recruitment_details>
      <pre_assignment_details>Excluded if did not meet inclusion or did meet exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>V60 First</title>
          <description>Experimental Study device (used as the experimental device) first in the cross-over study</description>
        </group>
        <group group_id="P2">
          <title>Conventional First</title>
          <description>Experimental Study device (used as the experimental device) second in the cross-over study</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>V60 First</title>
          <description>Experimental Study device (used as the experimental device) first in the cross-over study</description>
        </group>
        <group group_id="B2">
          <title>Conventional First</title>
          <description>Experimental Study device (used as the experimental device) second in the cross-over study</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="3"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="16.0" spread="0"/>
                <measurement group_id="B2" value="11.5" spread="4.9"/>
                <measurement group_id="B3" value="13.0" spread="4.4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Canada</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Breathing Comfort</title>
        <description>Comfort on visual analog scale 0 - 100, 0 is best</description>
        <time_frame>30 minutes</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>Analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>V60 First</title>
            <description>Experimental Study device (used as the experimental device) first in the cross-over study</description>
          </group>
          <group group_id="O2">
            <title>Conventional First</title>
            <description>Experimental Study device (used as the experimental device) second in the cross-over study</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Breathing Comfort</title>
            <description>Comfort on visual analog scale 0 - 100, 0 is best</description>
            <units>visual analog scale</units>
            <param>Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <sub_title>V60</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="10" spread="0"/>
                  <measurement group_id="O2" value="40" spread="14.1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Conventional</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="33.3" spread="0"/>
                  <measurement group_id="O2" value="45" spread="7.1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Saturation of Arterial Oxygen</title>
        <time_frame>30 minutes</time_frame>
        <safety_issue>Yes</safety_issue>
        <posting_date>12/2011</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Rate</title>
        <description>Breathing rate in breaths per minute</description>
        <time_frame>30 minutes</time_frame>
        <safety_issue>Yes</safety_issue>
        <posting_date>12/2011</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Minute Ventilation</title>
        <description>Liters per minute that the patient breathes</description>
        <time_frame>30 minutes</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate</title>
        <description>Beats per minute that the patient's heart is beating</description>
        <time_frame>30 minutes</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Pressure</title>
        <description>Systolic and diastolic blood pressure</description>
        <time_frame>30 minutes</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>V60 First</title>
          <description>Experimental Study device (used as the experimental device) first in the cross-over study</description>
        </group>
        <group group_id="E2">
          <title>Conventional First</title>
          <description>Experimental Study device (used as the experimental device) second in the cross-over study</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0"/>
                <counts group_id="E2" subjects_affected="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>10</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0"/>
                <counts group_id="E2" subjects_affected="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Terminated before 20 patients enrolled</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Adam Seiver</name_or_title>
      <organization>Respironics California</organization>
      <phone>760-703-6993</phone>
      <email>adam.seiver@philips.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
